Catalyst Wire Dossier Catalyst Wire Dossier

ERYTHROMYCIN ETHYLSUCCINATE

erythromycin ethylsuccinate · Azurity Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for ERYTHROMYCIN ETHYLSUCCINATE, covering 2006-08-10 to 2022-11-21. Get the full timeline:

Most recent: FDA Approved: ERYTHROMYCIN ETHYLSUCCINATE — Original Application (Cadila Pharmaceuticals Limited)

See pricing